The average Par Pharmaceuticals Investor Relations in New York earns an estimated $84,067 annually. Par Pharmaceuticals' Investor Relations compensation is $2,137 more than the US average for a Investor Relations.
Last updated 4 years ago.
The majority of Investor Relations at Par Pharmaceuticals believe they're compensated fairly. The vast majority (100%) of Investor Relations at Par Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Par Pharmaceuticals